Lvguidingan

CAS No. 82351-05-1

Lvguidingan ( Anticonvulsant 7903; Lvguidingan; Chlocibutamine )

Catalog No. M17605 CAS No. 82351-05-1

Lvguidingan is an Anticonvulsant agent.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 65 In Stock
10MG 102 In Stock
25MG 205 In Stock
50MG 309 In Stock
100MG 447 In Stock
500MG 972 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lvguidingan
  • Note
    Research use only, not for human use.
  • Brief Description
    Lvguidingan is an Anticonvulsant agent.
  • Description
    Lvguidingan, also known as Anticonvulsant 7903, is an Anticonvulsant agent.
  • Synonyms
    Anticonvulsant 7903; Lvguidingan; Chlocibutamine
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82351-05-1
  • Formula Weight
    272.17
  • Molecular Formula
    C13H15Cl2NO
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CCC(C)NC(=O)/C=C/c1cc(c(cc1)Cl)Cl
  • Chemical Name
    (E)-N-butan-2-yl-3-(3,4-dichlorophenyl)prop-2-enamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Patejdl R, et al. Phenytoin inhibits contractions of rat gastrointestinal and portal vein smooth muscle by inhibiting calcium entry. Neurogastroenterol Motil. 2015 Oct;27(10):1453-65.
molnova catalog
related products
  • Indobufen

    Indobufen is an inhibitor of platelet aggregation and is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes.

  • Licofelone

    Licofelone is a dual COX/LOX inhibitor potentially for the treatment of osteoarthritis.?Licofelone is both an analgesic and an anti-inflammatory.

  • FPL 62064

    FPL 62064 is a potent ?dual inhibitor of 5-lipoxygenase (5-LOX) and COX (IC50 of 3.5 μM and 3.1 μM for RBL-1 cytosolic 5-lipoxygenase and prostaglandin synthetase respectively).?